Introduction
Chronic pain (CP) is defined as pain lasting more than 3 months; its prevalence varies from 17 to 40% in the general adult population and increases with age [Reference Kennedy, Roll, Schraudner, Murphy and McPherson1, Reference Bouhassira, Lantéri-Minet, Attal, Laurent and Touboul2]. CP remains a major health problem, impacting patients’ self-perceived state of health, severely affecting the quality of their social and professional lives, and closely linked to depressive symptoms [Reference Reid, Harker, Bala, Truyers, Kellen and Bekkering3]. CP mean duration is widely varying according to its etiologies, and in a previous paper, we found that 25% of CP suffers living in the community recovered from their pain over 5 years [Reference Rouch, Strippoli, Dorey, Ranjbar, Laurent and von Gunten4]. Independently from comorbidities, CP is associated with low educational level, socioeconomic status, female gender, and mood disorders impacting on patient-perceived health status, their quality of social and working lives, with a significant link to depressive symptoms [Reference Reid, Williams, Concato, Tinetti and Gill5, Reference Reid, Williams and Gill6]. In middle-aged and older community-based adults, CP is mainly related to rheumatologic conditions. However, even in this population, CP mechanism may remain unexplained, as in the case of nociplastic pain without objective lesions [Reference Cohen, Quintner and Weisman7]. The main pathophysiological mechanism for developing nociplastic pain is central sensitization in which pain amplification and hypersensitivity occur. Nociplastic pain may be defined by multisite localization and some painful characteristics found by DN4-7 scale designed to assess neuropathic pain but showing an overlap with nociplastic one [Reference Erden, Turk, Erden and Dag8]. Research has shown that adverse childhood events (ACEs) have lifelong effects on mental health, health-damaging behaviors, relational functioning, and physical health [Reference Copeland, Shanahan, Hinesley, Chan, Aberg and Fairbank9, Reference Felitti, Anda, Nordenberg, Williamson, Spitz and Edwards10], including CP. ACEs promote central pain sensitization by modifying cerebral plasticity in early life [Reference Gerin, Viding, Herringa, Russell and McCrory11]. Few studies assessed prospectively the link between ACEs and the subsequent development of CP [Reference Generaal, Vogelzangs, Macfarlane, Geenen, Smit and de Geus12].
People experiencing this type of CP reliably show higher rates of adverse life experience [Reference Generaal, Vogelzangs, Macfarlane, Geenen, Smit and de Geus12] compared with the general population, and these biopsychosocial factors predict onset, quality, chronicity, and severity of pain [Reference Caselli, Dueck, Locke, Henslin, Johnson and Woodruff13–Reference Sullivan, Sturgeon, Lumley and Ballantyne15]. Specifically, these ACEs and traumatic exposures have been associated with a greater prevalence of multisite CP, particularly nociplastic pain [Reference Anderberg, Marteinsdottir, Theorell and von Knorring16–Reference Gupta, Silman, Ray, Morriss, Dickens and MacFarlane18].
Most previous research on the associations between adverse life experiences and traumatic exposures with CP was focused on specific clinical populations. Thus, ACEs were associated with chronic widespread pain and fibromyalgia in numerous cross-sectional studies [Reference Anderberg, Marteinsdottir, Theorell and von Knorring16, Reference Hellou, Häuser, Brenner, Buskila, Jacob and Elkayam19–Reference Ranney, Maguen, Bernhard, Holder, Vogt and Blosnich23]. However, the association between ACEs and CP may reflect selection and recall bias in cross-sectional studies [Reference McBeth, Morris, Benjamin, Silman and Macfarlane22] inciting to explore longitudinal data. A large-scale prospective cohort in the United Kingdom reported an association between several adverse events collected during childhood and the presence of CP in adulthood, independently from psychological distress [Reference Jones, Power and Macfarlane24]. In most studies, the analyses focused on the relationship between physical or sexual abuse and CP. However, the role of other types of ACEs and their impact according to age of onset on the later development of different types of CP is still debated. Some previous studies have highlighted an increased risk of developing CP in adulthood [Reference Generaal, Vogelzangs, Macfarlane, Geenen, Smit and de Geus17], but the respective roles of adversity, personality and mood disorders in the development of CP remain unclear. Numerous studies have demonstrated the link between ACEs and functional CP in children, adolescents, and young adults, particularly in clinical populations [Reference Tan, Jaaniste and Champion25]. On the other hand, the origin of certain forms of adult-onset CP is not well understood; in particular, little is known about the potential link between ACEs and the onset of CP in this population.
In a previous study of a large population of middle-aged and older community dwellers initially free of CP, we showed that higher neuroticism and extraversion, and to a lesser extent the presence of ACEs, influenced CP occurrence independently from anxiety or major depressive disorders (MDD) [Reference Rouch, Strippoli, Dorey, Ranjbar, Laurent and von Gunten4]. Hence, we aimed to assess the prospective association between the number and different types of ACEs reported in the beginning of a follow-up (FU) interval and the subsequent development of multisite and non-multisite CP during this interval with and without subtyping into neuropathic versus non-neuropathic CP, controlling for various potential confounders, including demographic factors, personality traits, and lifetime major depressive and anxiety disorders.
Methods
Participants
The present data stem from CoLaus|PsyCoLaus, a prospective population-based cohort study designed to investigate cardiovascular risk factors and mental disorders in the community and to determine their associations. The study was previously described in detail [Reference Firmann, Mayor, Vidal, Bochud, Pécoud and Hayoz26, Reference Preisig, Waeber, Vollenweider, Bovet, Rothen and Vandeleur27]. CoLaus|PsyCoLaus initially included a sample of 6734 participants (age range: 35–75 years) randomly selected from the residents of the city of Lausanne, Switzerland, between 2003 and 2006. After the first physical and psychiatric assessment, which took place between 2003 and 2008, the cohort was followed between 2009 and 2013 (FU1), 2014 and 2018 (FU2) as well as between 2018 and 2021 (FU3). Since FU FU1, participants have been invited to complete pain questionnaires during the physical investigation. The duration of the FU interval between FU1 and FU2 was 5.2 (s.d. 0.5) years and that between FU2 and FU3 was 3.8 (0.4) years. A total of 2932 participants completed both the psychiatric evaluation and the pain questionnaires at least at two of the three FU evaluations (Figure 1). After excluding individuals with CP in the beginning of the interval (an interval corresponds to a period between two pain assessments from FU1 to FU2 or from FU2 to FU3), missing information on personality, neuropathic or non-neuropathic pain, or type of ACEs, the final sample included 1537 participants with 2161 analyzable intervals (49.7% men, mean age [s.d.] 57.3 [9.7] years) consisting of 1215 and 946 analyzable intervals from FU1 to FU2 and from FU2 to FU3, respectively. For the 1746 participants who completed the psychiatric evaluations and the pain questionnaires at all three FU evaluations, the two intervals from FU1 to FU2 and from FU2 to FU3 were separately analyzed.
Flowchart of CoLaus|PsyCoLaus for the study of personality traits and early-life adversity and the incidence of multisite chronic pain. Analyzable interval.
Assessments
Pain
Participants underwent pain assessments at FU1, FU2, and FU3 using the STOPNEP questionnaire, an 11-question pain inventory designed and validated for epidemiological studies [Reference Bouhassira, Lantéri-Minet, Attal, Laurent and Touboul2]. The first two questions aimed at identifying the presence of daily pain for at least three months, which define CP according to the International Association for Study of Pain [Reference Treede, Rief, Barke, Aziz, Bennett and Benoliel28].
Participants who responded positively to these two questions had to locate their pain from a list of body parts and to report the location of the most troublesome pain if appropriate. The number of pain sites was calculated for each participant, and according to literature [Reference Imbierowicz and Egle21] multisite CP was defined as follows: “multisite” when the number of pain sites was >3 sites, and “non-multisite” for one to three sites.
DN4 questionnaire (short form with seven questions) [Reference Bouhassira, Attal, Alchaar, Boureau, Brochet and Bruxelle29] was used to assess pain with neuropathic characteristics among participants with CP. The original version of the DN4 questionnaire consists of 10 items, in which 7 items are related to pain characteristics and 3 items are related to findings on physical examination of the painful areas. A short version based on the interview items was validated by the same authors for epidemiological studies. A score of 1 was given to each positive item and a score of 0 to each negative item. The total score was calculated as the sum of seven items. Participants with a total score ≥3 are considered to have neuropathic pain characteristics [Reference Bouhassira, Lantéri-Minet, Attal, Laurent and Touboul2].
ACEs, mood and anxiety disorders, personality traits, sociodemographic characteristics, and other covariates
Diagnostic information on mental disorders was elicited at each psychiatric evaluation using the French version [Reference Leboyer, Barbe, Gorwood, Teherani, Allilaire and Preisig30] of the DIGS [Reference Nurnberger31]. Interviewers were master-level psychologists trained over at least a one-month period. An experienced senior psychologist reviewed all interviews and diagnostic assignments. The French version of this instrument has adequate inter-rater and test–retest reliability for major mood disorders [Reference Preisig, Fenton, Matthey, Berney and Ferrero32]. The DIGS was completed with the post-traumatic stress disorder (PTSD) and the generalized anxiety disorder (GAD) sections of the French version [Reference Leboyer, Maier, Teherani, Lichtermann, D’Amato and Franke33] of the Schedule for Affective Disorders and Schizophrenia-Lifetime and Anxiety disorder version (SADS-LA) [Reference Endicott34], and the brief phobia chapter of the DIGS was replaced by the corresponding more extensive chapters of the SADS-LA. In addition, a section on childhood events from the SADS-LA was incorporated in the DIGS. At the FU evaluations, a shortened version of the DIGS was used focusing on the period since the last assessment. Lifetime diagnoses of MDD and anxiety disorders (agoraphobia, panic disorder, GAD, social phobia) until the first pain assessment were assigned according to the Diagnostic and Statistical Manual of Mental Disorders-fourth version [Reference Guze35].
Information about ACEs occurring before the age of 17 years was elicited at the first psychiatric evaluation using the questions on traumatic events in the PTSD and the childhood sections of the SADS-LA. The following stressful experiences were considered as indicators of early-life adversity: sexual or physical abuse (PTSD section), witnessing of violence between parents, divorce or separation of parents, and loss of close relatives (parents or siblings) (childhood section) [Reference Kessler, Berglund, Demler, Jin, Koretz and Merikangas36]. According to the suggestion by Friedman et al. [Reference Friedman, Montez, Sheehan, Guenewald and Seeman37], exposure to early-life adversity was also quantified by the sum of reported events.
Regarding personality traits, Neuroticism and Extraversion were assessed by the Eysenck Personality Questionnaire-Revised (EPQ-R) [Reference Eysenck and Eysenck38], which was completed at baseline and FU2, and the NEO Five-Factor Inventory (NEO-FFI-R) [Reference Costa and McCrae39] completed at FU1. If participants had completed the two questionnaires prior to the beginning of the analyzed FU interval, data from the EPQ-R were used. NEO-FFI score was used for participants with missing data on EPQ-R. Neuroticism and Extraversion scores from the two questionnaires were normalized, and the z-scores were used for analyses.
During the physical evaluations, information was collected on sociodemographic characteristics including age, sex, education as well as medication (analgesics [ATC code N02], opioids [ATC code N02A + N02BG01], antidepressants [ATC code N06A], and anxiolytics [ATC code N05B]). Education was categorized into four levels: compulsory school, apprenticeship, high school/college, and university degrees.
Sleep and fatigue
Previous studies have shown an overlap between neuropathic symptoms diagnosed with the DN4-7 and fibromyalgia, defined by multisite musculoskeletal pain accompanied by fatigue and sleep disturbance. In order to better characterize the subtype of CP linked to ACEs (i.e., DN4+ multisite pain) and to determine whether these subjects suffered from fibromyalgia, the prevalence of sleep disorders and fatigue were assessed.
Sleep quality was assessed using Pittsburgh Sleep Quality Index (PSQI), a self-administered questionnaire assessing sleep quality and disorders for the month preceding the evaluation [Reference Buysse, Reynolds, Monk, Berman and Kupfer40]. The participants were asked to rate each component using a 4-point Likert scale, ranging from 0 to 3 points with a maximum overall score of 21 points. A score >5 reflects sleep disorders.
Fatigue was measured by the Krupp fatigue severity scale (FSS), consisting of a nine-item questionnaire [Reference Krupp41] and validated in the community in a Swiss population [Reference Valko, Bassetti, Bloch, Held and Baumann42]. Respondents answered using a Likert scale ranging from 1 (completely disagree) to 7 (completely agree), a high score indicating a high level of fatigue. For each respondent, the sum scores for the nine items were divided by the number of items. A score >4 is considered as pathological.
Statistical analysis
Participants who had no CP in the beginning of the interval were divided into three groups according to the CP status at the end of the interval: no CP, non-multisite (one to three sites) CP, multisite (>3 sites) CP. Continuous variables were presented as mean with standard deviation (s.d.) and categorical variables were expressed as percentages. To explore the association between early-life adversity (witnessing of violence between parents, divorce or separation of parents, loss of close relatives [parents or siblings], sexual and physical abuse, and number of childhood events) and the incidence of multisite CP at the end of the interval, namely no CP, non-multisite CP, multisite CP, multinomial logistic regression analyses were performed, as the proportional odds assumption was also rejected after score test for ordinal logistic. The multinomial logistic regression models were fitted with no CP at the end of the interval as the reference level. These models were all adjusted for sex; age; education; duration of FU; FU interval (FU1 to FU2 or FU2 to FU3); medication (analgesics, antidepressants, anxiolytics) at the end of the interval; presence of non-CP at the beginning of the interval; personality traits (neuroticism, extraversion); lifetime mental disorders (MDD and anxiety disorders); and intrapersonal correlations were taken into account by using generalized estimating equation methods. Model 1 was separately run for number of childhood events, witnessing of violence between parents, divorce or separation of parents, loss of close relatives (parents or siblings), and sexual and physical abuse. Model 2 included all types of ACEs simultaneously. Moreover, to better specify the psychological profile of the participants, the rate of MDD history in participants’ parents was compared between those with and without parental divorce or separation; finally, the age of the participants when their parents divorced was compared between the CP groups among participants with parental divorce.
To specify the type of CP may be influenced by early psychological factors, complementary analyses were conducted with regard to neuropathic pain characteristics assessed by DN4 scale. To explore the association between the different ACEs and the incidence of neuropathic or non-neuropathic multisite CP at the end of the interval, a five-category variable was created as follows: “no CP,” “non-multisite non-neuropathic (DN4−) CP, “non-multisite neuropathic (DN4+) CP,” “multisite non-neuropathic (DN4−) CP,” and “multisite neuropathic (DN4+) CP,” and multinomial logistic regression analyses were performed with no CP at the end of the interval as the reference level.
To better characterize DN4 characteristics, they were described in detail for subjects from “multisite DN4+ CP” group. The proportion of subjects with sleep disorders according to PSQI and fatigue according to FSS were compared between participants with “multisite DN4+ CP” and those without CP.
The results were considered as statistically significant at the level of p-value <0.05. All statistical analyses were conducted using SAS software (V. 9.4) (SAS Institute Inc., Cary, NC, USA).
Results
Descriptive results
Pain locations
Among subjects exhibiting CP, the most frequent locations concerned back (54.3%, 43.8% with lower back), knees (32.5%), shoulders (29.4%), feet (22.9%), hips (22.6%), and hands (20.5%).
The sociodemographic and clinical characteristics of the participants according to “multisite CP,” “non-multisite CP,” and “no CP” at the end of the interval are presented in Table 1.
Description of the sample according to the presence of multisite chronic pain in the end of the follow-up interval among participants without chronic pain in the beginning of the follow-up interval
Abbreviations: CP, chronic pain; s.d., standard deviation; NA: not available.
Prevalence of ACEs among the participants
Among the participants, exposure to at least one ACE was common, respectively, 38.2% of the subjects from “multisite CP” group, 28.8 % of the “non-multisite CP,” and 24.7% of the “no CP” one. Furthermore, 19.5% of the subjects were exposed to one traumatic event, 5.3% were exposed to two, and 1% were exposed to three such events.
Crude associations between ACEs and subsequent multisite CP
The prospective associations between ACEs assessed in the beginning of the interval and multisite CP emerging during the FU interval are displayed in Table 2. The models run for the number of ACEs and each type of ACE separately (Model 1) revealed a higher risk of developing multisite CP in participants who had reported a higher number of ACEs, and in those who had been exposed to parental divorce or separation in comparison to individuals without these exposures. Moreover, participants who had lost a parent or a sibling had a greater risk of having “non-multisite CP” than those without CP. When all ACEs were assessed in a single model (Model 2), only the association of parental divorce or separation with a higher risk of developing multisite CP remained significant.
Associations between early-life (before age 17 years) adversity and the presence of multisite chronic pain in the end of the follow-up interval among participants without chronic pain in the beginning of the follow-up interval (n = 2161)
Note: °p < 0.1, *p < 0.05.
Model 1: Each line corresponds to one multinomial logistic regression model.
Model 2: One single multinomial logistic regression model with each type of early-life adversity entered simultaneously.
All models were adjusted for sex; age; education; duration of follow-up interval; follow-up interval (FU1 to FU2 or FU2 to FU3); medication (analgesics, antidepressants, anxiolytics) in the end of the follow-up interval; presence of non-chronic pain at the beginning of the follow-up interval; personality (neuroticism, extraversion); lifetime mental disorders (major depressive disorder, anxiety disorders [agoraphobia, panic disorder, generalized anxiety disorder, social phobia]); and intrapersonal correlations.
The multinomial logistic regression models were fitted with no chronic pain in the end of the interval as the reference level.
Abbreviations: CP, chronic pain; RR, relative risk; 95CI, 95% confidence interval.
Bold entries mean significant results.
Age of exposure has been assessed for ACEs. No significant association was found between age of exposure to ACEs and risk of CP occurrence (data not shown).
Relationship between ACEs and subsequent multisite CP with neuropathic characteristics
The association between ACEs and multisite CP with respect to neuropathic characteristics (DN4+ and DN4−) is presented in Table 3. Our results revealed a higher risk of developing multisite DN4+ CP in subjects with parental divorce or separation history when compared to participants without parental divorce or separation history.
Associations between early-life (before age 17 years) adversity and the presence of neuropathic and non-neuropathic multisite chronic pain at the end of the follow-up interval among participants without chronic pain in the beginning of the follow-up interval (n = 2161)
Note: °p < 0.1; *p < 0.05; **p < 0.01.
Model 1: Each line corresponds to one multinomial logistic regression model.
Model 2: One single multinomial logistic regression model with each type of early-life adversity entered simultaneously.
All models were adjusted for sex; age; education; duration of follow-up; follow-up interval (FU1 to FU2 or FU2 to FU3); medication (analgesics, antidepressants, anxiolytics) at the end of the follow-up interval; presence of non-chronic pain at the beginning of the follow-up interval; personality (neuroticism, extraversion); lifetime mental disorders (major depressive disorder, anxiety disorders [agoraphobia, panic disorder, generalized anxiety disorder, social phobia]); and intrapersonal correlations. The multinomial logistic regression models were fitted with no chronic pain at the end of the follow-up interval as the reference level.
Abbreviations: CP, chronic pain; RR, relative risk; 95CI, 95% confidence interval.
Bold entries mean significant results.
Regarding DN4 characteristics among participants with “multisite DN4+ CP,” 92.9% of them felt numbness, 85.7% presented sensations of tingling, 81.8% of pins and needles, 75% electric shocks, 72.7% of them felt burning, 37.5% had itching, and 25% had painful cold. Moreover, 60% of the participants with “multisite DN4+” CP reported sleep disorders (vs. 42.1% of “non-multisite DN4+,” 42.1% of “non-multisite DN4−” and 24% of those without CP, χ2 = 21.2, p < 0.0001), and 13.3% presented fatigue (vs. 23.8% of “non-multisite DN4+” group, 8.5% of “non-multisite DN4−” and 6.3% out of those without CP, χ2 = 25.5, p < 0.0001).
Discussion
To our knowledge, this study is the first to assess the prospective associations of different types of ACEs with the incidence of CP over a 5.5-year period in a cohort of middle-aged and older community-dwellers. Our main findings were as follows: (1) the presence and the number of ACEs were linked to a higher risk of developing multisite CP over time; (2) among ACEs, parental divorce or separation was associated with higher incidence of multisite CP; (3) parental divorce or separation were strongly associated with multisite CP with DN4 characteristics as nociplastic ones; and (4) the higher CP occurrence in individuals with parental divorce or separation was not explained by potential confounders, including sociodemographic characteristics, comorbid mental disorders or psychological characteristics, antidepressant, or analgesic medications.
The strong association found between ACEs and multisite CP confirms findings from previous research where an excess of ACEs was associated with chronic multisite pain in numerous cross-sectional studies [Reference Anderberg, Marteinsdottir, Theorell and von Knorring16, Reference Hellou, Häuser, Brenner, Buskila, Jacob and Elkayam19, Reference Varinen, Kosunen, Mattila, Koskela and Sumanen20]. However, the majority of these studies have examined ACEs retrospectively in participants with or without multisite CP, and have been shown to be sensitive to recall bias: people remember past events with different degrees of accuracy, which can lead to inaccurate estimates of the risk associated with exposure [Reference McBeth, Morris, Benjamin, Silman and Macfarlane22]. Regarding longitudinal research, our results are compatible with the findings from Jones et al. [Reference Jones, Power and Macfarlane24] showing that family difficulties during childhood before 7 years were associated with widespread pain in adulthood, including a trend to significance for divorce/separation (OR 1.3, CI 0.99–1.7). However, in their study, childhood events were not directly measured from participants but by maternal report. According to the frequency of familial aggregation between widespread pain, in particular fibromyalgia, and familial depression, the authors suggested that the mothers of children who developed CP had higher rates of depression themselves, and could over-report ACEs in their children [Reference Jones, Power and Macfarlane24]. In our study, ACEs were collected from adult participants prior to the onset of CP, thereby excluding this bias.
Regarding the association between ACE types and multisite CP, our results differ from the literature insofar as parental divorce was the sole predictor of the development of multisite CP with neuropathic features. A recent large cross-sectional study showed that parental divorce was weakly associated with CP at midlife (OR 1.26), but not specifically with widespread pain [Reference Salonsalmi, Pietiläinen, Lahelma, Rahkonen and Lallukka43]. On the other hand, we failed to show a relationship between sexual or physical abuse or loss of a family member, and the development of multisite CP, as frequently found in previous studies [Reference Generaal, Vogelzangs, Macfarlane, Geenen, Smit and de Geus12, Reference Afari, Ahumada, Wright, Mostoufi, Golnari and Reis44]. In other respects, witnessing of violence between parents was significantly linked to multisite CP when assessed individually, but it became nonsignificant in model 2 when all types of ACEs were entered simultaneously. Indeed, witnessing of parental violence is frequent before and sometimes after divorce. However, in our cohort, parental divorce explained multisite CP independently from witnessing violence. Parental divorce is often accompanied by single-parent upbringing, usually by the mother. However, an earlier study highlighted the role of paternal education (care and encouragement of freedom) as a protective factor against CP in adulthood [Reference Anno, Shibata, Ninomiya, Iwaki, Kawata and Sawamoto45]. Moreover, raising children alone is probably more stressful for the single parent, and may reinforce neuroticism in children, and particularly high levels of neuroticism may positively influence the onset of CP [Reference Rouch, Strippoli, Dorey, Ranjbar, Laurent and von Gunten4]. High levels of neuroticism or extraversion may also modify the recall of ACEs, as may depression, favoring a negative bias in the recall of traumatic events. The association between parental divorce and multisite CP, particularly with neuropathic features, remained highly significant after accounting for these factors.
When considering our participants with multisite CP and DN4+, several symptoms were frequent, in particular, tingling, pins, and needles and sensations of numbness. These symptoms are also frequently found in fibromyalgia, which is known to be strongly favored by ACEs, and should prompt discussion of the differential diagnosis between neuropathic pain and fibromyalgia. Moreover, symptoms explored by the DN4 that are the most specific to neuropathic pain, such as the sensation of painful cold, were infrequent in our cohort. To clarify the type of pain in this group with multisite DN4+ CP, we assessed the prevalence of other core symptoms of fibromyalgia, notably sleep disorders, and chronic fatigue. The latter symptom was rarely present in our participants indicating that they were unlikely to be affected with fibromyalgia. Furthermore, as our participants had an average age of 58 years and fibromyalgia typically emerges before this age [Reference Nielson and Jensen46], we can assume that most participants with this condition would have already presented CP in the beginning of the first interval, and thereby, they would have been eliminated from the present analyses.
Previous research has highlighted that individual risks of developing CP may be increased by ACE-induced alterations during neurodevelopment in key neurobiological substrates, such as the hypothalamic-pituitary-adrenal axis [Reference Burke, Finn, McGuire and Roche47, Reference Werthman, Colloca and Oswald48]. In addition, ACEs have been shown to modulate emotional responses to pain [Reference Rouch, Strippoli, Dorey, Ranjbar, Laurent and von Gunten4]. These effects may be the result of long-lasting ACE-related changes during early neurodevelopment. In CP patients, ACE-related alterations in intrinsic connectivity have been observed in the salience or executive control network, which is involved in central pain amplification. Connections between amygdala and prefrontal circuits have been shown to be particularly sensitive to early-life events [Reference Gerin, Viding, Herringa, Russell and McCrory11]. Changes in these brain networks may contribute to the development of neural and behavioral patterns persisting during adulthood. In addition, frontal executive control becomes less effective with aging [Reference Salthouse49], which could explain the onset of CP in middle-aged and older adults [Reference Werthman, Colloca and Oswald48].
Limitations
Several limitations should be considered when interpreting our study results. First, adult memory of childhood trauma is subject to incomplete recall. However, due to the prospective design with information on ACEs being collected prior to the emergence of CP, the likelihood of reporting ACEs should not have been influenced by the outcome status, ruling out the risk of recall bias. Second, the DN4 questionnaire has only been validated in patients attending CP centers, where the prevalence of CP, particularly neuropathic pain, is high [Reference Bouhassira, Attal, Alchaar, Boureau, Brochet and Bruxelle29]. However, there are no validation data available from community samples, where the prevalence of neuropathic CP is much lower, varying from 7 to 10% [Reference Bouhassira, Lantéri-Minet, Attal, Laurent and Touboul2, Reference van Hecke, Austin, Khan, Smith and Torrance50], which may decrease the accuracy of the DN4 questionnaire (its positive predictive value) for diagnosing neuropathic CP [Reference Hardt, Bergau, Jacques and Tampin51]. Furthermore, it would have been interesting to prospectively collect traumatic events and CP in childhood, and follow the development of CP in adulthood, but our cohort included subjects aged 35 and over. Indeed, as our analysis focused on subjects whose CP occurred after the age of 40, we were unable to take into account subjects whose CP occurred during childhood, adolescence, or early adulthood, which are known to be strongly associated with severe and/or multiple ACE-related trauma.
Moreover, exposure to at least one traumatic event during childhood was frequent in our study, but the prevalence of ACEs observed in our study is lower than that found in the literature [Reference Copeland, Shanahan, Hinesley, Chan, Aberg and Fairbank9, Reference Madigan, Deneault, Racine, Park, Thiemann and Zhu52]. However, it is very difficult to compare the frequency of ACEs in the present study with that of other studies, as there are virtually no other studies that have evaluated exactly the same list of events. In a previous article, we compared the occurrence of well-specified PTSD events in our sample with that of other studies. Compared with studies carried out in most other European countries or outside Europe, the lower prevalence of lifetime exposure to traumatic events is consistent with that of two Swiss and German studies [Reference Perrin53].
Additionally, PTSD could be a mediator between ACEs and CP. However, we found no association between sexual/physical abuse and witnessing domestic violence, which are typical triggers of PTSD. Nevertheless, a complementary analysis assessing the association between ACEs and CP also controlled for PTSD, which did not modify the results (data not shown). Finally, the limited number of subjects with both multisite CP+/DN4+ and a history of parental divorce may preclude the generalizability of the present results. Further longitudinal studies with a prospective collection of ACEs and CP, larger numbers of subjects, and longer FU are needed to confirm the present results.
Conclusion
Our results show that among childhood adversities, parental divorce or separation, a frequent event that is considered quite trivial, strongly increases the risk of developing multisite CP as a middle-aged adult, specifically with neuropathic features, in a general population without CP at baseline. These results suggest the value of multimodal management, including psychotherapy, for the prevention or management of health problems including CP. Indeed, the clinical experience of CP centers suggests the usefulness of a multidimensional approach, integrating the patient’s autobiographical background. In particular, explaining to adults suffering from CP that their pain may be linked to events in their lives can help them to better understand and manage their pain.
Data availability statement
The data of CoLaus|PsyCoLaus study used in this article cannot be fully shared as they contain potentially sensitive personal information on participants. According to the Ethics Committee for Research of the Canton of Vaud, sharing these data would be a violation of the Swiss legislation with respect to privacy protection. However, coded individual-level data that do not allow researchers to identify participants are available upon request to researchers who meet the criteria for data sharing of the CoLaus|PsyCoLaus Datacenter (CHUV, Lausanne, Switzerland). Any researcher affiliated to a public or private research institution who complies with the CoLaus|PsyCoLaus standards can submit a research application to research.colaus@chuv.ch or research.psycolaus@chuv.ch. Proposals requiring baseline data only, will be evaluated by the baseline (local) Scientific Committee (SC) of the CoLaus and PsyCoLaus studies. Proposals requiring follow-up data will be evaluated by the follow-up (multicentric) SC of the CoLaus|PsyCoLaus cohort study. Detailed instructions for gaining access to the CoLaus|PsyCoLaus data used in this study are available at www.colaus-psycolaus.ch/professionals/how-to-collaborate/.
Acknowledgments
The authors express their gratitude to the Lausanne inhabitants who volunteered to participate in the CoLaus|PsyCoLaus study and to all the collaboratorVoir avec Martin pourquoi moins d’ACEs que dans les autres pop? nns who contributed to the coordination of the study and the collection of data. The authors thank Pr Vollenweider and Pr Weber, who designed and coordinated the Colaus cohort.
Author contribution
IR managed the redaction of the different versions of the paper. IR, MP, JMD, BL, MP, and AVG designed the present paper. MP and AVG designed the Psycolaus cohort. MPS managed the data. MPS and SR made the statistical analysis. JMD, BL, PMMV, CB, MS, JV, MPS, SR, AVG, and MP discussed the results and significantly contributed to the manuscript redaction.
Financial support
The CoLaus|PsyCoLaus study was and is supported by unrestricted research grants from GlaxoSmithKline; the Faculty of Biology and Medicine of Lausanne; and the Swiss National Science Foundation (grants 3200B0–105993, 3200B0-118308, 33CSCO-122661, 33CS30-139468, 33CS30-148401, 33CS30_177535, and 3247730_204523) and the Swiss Personalized Health Network (grant 2018DRI01). The funder had no role in the design, data collection, data analysis, and reporting of this study.
Ethical standard
The institutional Ethics Committee of the University of Lausanne, which afterward became the Ethics Commission of the Canton of Vaud (www.cer-vd.ch) approved the baseline CoLaus|PsyCoLaus study (reference 16/03; 134-03,134-05bis, 134-05-2to5 addenda 1to4). The approval was renewed for the first (reference 33/09; 239/09), the second (reference 26/14; 239/09 addendum 2) and the third (PB_2018-00040; 239/09 addenda 3to4) follow-ups. The study was performed in agreement with the Helsinki declaration and its former amendments, and in accordance with the applicable Swiss legislation. All participants signed a written informed consent
Competing interest
The authors declare no conflict of interest in relation to the present article.
Open access
Comments
No Comments have been published for this article.